Not available outside of the UK & Ireland.

Application

Streptokinase is commonly used as a thrombolytic agent in the therapy of ischemic stroke. This therapy carries the important risk of intracerebral hemorrhage. Streptokinase is also used in the treatment of complicated parapneumonic effusions and empyema where adverse reactions, allergic type, are rare. Streptokinase has been used in a study to compare primary coronary intervention and thrombolytic therapy in myocardial infarction patients.

Streptokinase is commonly used as a thrombolytic agent in the therapy of ischemic stroke. This therapy carries the important risk of intracerebral hemorrhage. Streptokinase is also used in the treatment of complicated parapneumonic effusions and empyema where adverse reactions, allergic type, are rare.

General description

Streptokinase from β-hemolytic Streptococcus, or Streptokinase from Streptococcus hemolyticus, is effective in thrombolytic therapy.

Packaging

10000, 50000, 250000 units in glass bottle

Physical form

Lyophilized powder containing ~50% total protein by biuret and sodium glutamate. Total protein composed of enzyme protein and human serum albumin.

Unit Definition

One unit is equal to the amount of activity in one unit from a Streptokinase International Standard reference vial.